The start of 2025 hasn't been great for the markets. After coming off a strong performance in 2024, when the S&P 500 ...

Intel faced fierce competition and strategic shifts last year. Is the company poised for a comeback in the near future?

Undervalued biotech company Regenxbio Inc. shows promise with cutting-edge gene therapy technology for AMD and MPS II. Click ...

Following Donald Trump's victory in the U.S. presidential election on Nov. 5, Tesla stock found new life. Between Nov. 4 and Dec. 31, shares gained 66.3%, and the company reclaimed its position in the ...

NEW YORK — Target has shortened its go-to-market cycle to eight weeks, down from 27, for specific trending items so they can ...

With a loss of 4.5% during December, the Model Shadow Stock Portfolio ended 2024 in the red, down 4.7%. Market sentiment turned negative due to concerns over persistent inflation, high interest and ...

Blue Owl Capital Corporation can be a compelling choice for investors seeking high yields. Read more to see why I'm neutral ...

Harvard is now testing an AI tool that can compare job seekers' resumes with their preferred roles and recommend online ...

US-based short-seller Hindenburg Research announced its closure, with founder Nate Anderson citing personal growth and ...

JPMorgan Chase (NYSE: JPM) Q4 2024 Earnings Call Jan 15, 2025, 8:30 a.m. ET Good morning, ladies and gentlemen. Welcome to ...

Potawatomi is expanding beyond the casino business. It is building a new chain of convenience stores and gas stations, with ...

Get the latest news, fund ideas, market commentary and opinions from Fidelity’s savings and investment experts on investing ...